Cargando…
Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern
OBJECTIVES: Antigen rapid diagnostic tests (Ag-RDTs) play an important role in the diagnosis of SARS-CoV-2. They are easier, quicker, and less expensive than the ‘reference standard’ RT-PCR and therefore widely in use. Reliable clinical data with respect to Ag-RDT performance in SARS-CoV-2 Omicron v...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181871/ https://www.ncbi.nlm.nih.gov/pubmed/37182639 http://dx.doi.org/10.1016/j.cmi.2023.05.009 |
_version_ | 1785041668769054720 |
---|---|
author | Bornemann, Linus Kaup, Olaf Kleideiter, Johannes Ruprecht, Bertram Hoyer, Annika Panning, Marcus Bornemann, Reinhard Wehmeier, Michael |
author_facet | Bornemann, Linus Kaup, Olaf Kleideiter, Johannes Ruprecht, Bertram Hoyer, Annika Panning, Marcus Bornemann, Reinhard Wehmeier, Michael |
author_sort | Bornemann, Linus |
collection | PubMed |
description | OBJECTIVES: Antigen rapid diagnostic tests (Ag-RDTs) play an important role in the diagnosis of SARS-CoV-2. They are easier, quicker, and less expensive than the ‘reference standard’ RT-PCR and therefore widely in use. Reliable clinical data with respect to Ag-RDT performance in SARS-CoV-2 Omicron variants of concern (VOCs) are limited. Consequently, the objective of this study was to determine the impact different VOCs—especially Omicron—have on the clinical performance of an Ag-RDT. METHODS: We compared the clinical performance of the Sofia SARS-CoV-2 Ag-RDT to RT-PCR in a real-world, single-centre study in a clinical point-of-care setting in patients admitted to a large hospital via the emergency department from 2 November 2020 to 4 September 2022. RESULTS: Among 38 434 Ag-RDT/RT-PCR tandems taken, 1528 yielded a SARS-CoV-2 positive RT-PCR test result, with a prevalence of 4.0% (95% CI, 3.8–4.2). Overall sensitivity of the Ag-RDT was 63.7% (95% CI, 61.3–66.1) and overall specificity was 99.6% (95% CI, 99.5–99.6). Ag-RDT sensitivity was dependent on viral load (VL), because the sensitivity increased to 93.2% (95% CI, 91.5–94.6) in samples with a VL > 10(6) SARS-CoV-2 copies/mL. Furthermore, the Ag-RDT was more sensitive in men, and older patients. Variant-dependent sensitivity assessment showed that the sensitivity was significantly lower in Omicron-VOC (64.1%; 95% CI, 60.5–67.6) compared with SARS-CoV-2 wild-type samples (70.0%; 95% CI, 59,8–78,6) (binomial test; p value < 0.001). Analysing the limits of detection showed a 27 times higher 95% limit of detection for the Omicron-VOC BA.5 compared with the SARS-CoV-2 wild-type. DISCUSSION: Ag-RDT sensitivity for detection of patients with lower VLs and with Omicron-VOC is reduced, limiting the effectiveness of Ag-RDTs. However, Ag-RDTs are still an unreplaceable tool for widely available, quick, and inexpensive point-of-care SARS-CoV-2 diagnostics. |
format | Online Article Text |
id | pubmed-10181871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101818712023-05-15 Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern Bornemann, Linus Kaup, Olaf Kleideiter, Johannes Ruprecht, Bertram Hoyer, Annika Panning, Marcus Bornemann, Reinhard Wehmeier, Michael Clin Microbiol Infect Original Article OBJECTIVES: Antigen rapid diagnostic tests (Ag-RDTs) play an important role in the diagnosis of SARS-CoV-2. They are easier, quicker, and less expensive than the ‘reference standard’ RT-PCR and therefore widely in use. Reliable clinical data with respect to Ag-RDT performance in SARS-CoV-2 Omicron variants of concern (VOCs) are limited. Consequently, the objective of this study was to determine the impact different VOCs—especially Omicron—have on the clinical performance of an Ag-RDT. METHODS: We compared the clinical performance of the Sofia SARS-CoV-2 Ag-RDT to RT-PCR in a real-world, single-centre study in a clinical point-of-care setting in patients admitted to a large hospital via the emergency department from 2 November 2020 to 4 September 2022. RESULTS: Among 38 434 Ag-RDT/RT-PCR tandems taken, 1528 yielded a SARS-CoV-2 positive RT-PCR test result, with a prevalence of 4.0% (95% CI, 3.8–4.2). Overall sensitivity of the Ag-RDT was 63.7% (95% CI, 61.3–66.1) and overall specificity was 99.6% (95% CI, 99.5–99.6). Ag-RDT sensitivity was dependent on viral load (VL), because the sensitivity increased to 93.2% (95% CI, 91.5–94.6) in samples with a VL > 10(6) SARS-CoV-2 copies/mL. Furthermore, the Ag-RDT was more sensitive in men, and older patients. Variant-dependent sensitivity assessment showed that the sensitivity was significantly lower in Omicron-VOC (64.1%; 95% CI, 60.5–67.6) compared with SARS-CoV-2 wild-type samples (70.0%; 95% CI, 59,8–78,6) (binomial test; p value < 0.001). Analysing the limits of detection showed a 27 times higher 95% limit of detection for the Omicron-VOC BA.5 compared with the SARS-CoV-2 wild-type. DISCUSSION: Ag-RDT sensitivity for detection of patients with lower VLs and with Omicron-VOC is reduced, limiting the effectiveness of Ag-RDTs. However, Ag-RDTs are still an unreplaceable tool for widely available, quick, and inexpensive point-of-care SARS-CoV-2 diagnostics. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023-05-12 /pmc/articles/PMC10181871/ /pubmed/37182639 http://dx.doi.org/10.1016/j.cmi.2023.05.009 Text en © 2023 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Bornemann, Linus Kaup, Olaf Kleideiter, Johannes Ruprecht, Bertram Hoyer, Annika Panning, Marcus Bornemann, Reinhard Wehmeier, Michael Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title | Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title_full | Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title_fullStr | Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title_full_unstemmed | Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title_short | Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern |
title_sort | virus variant-specific clinical performance of a sars-cov-2 rapid antigen test with focus on omicron variants of concern |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181871/ https://www.ncbi.nlm.nih.gov/pubmed/37182639 http://dx.doi.org/10.1016/j.cmi.2023.05.009 |
work_keys_str_mv | AT bornemannlinus virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT kaupolaf virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT kleideiterjohannes virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT ruprechtbertram virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT hoyerannika virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT panningmarcus virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT bornemannreinhard virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern AT wehmeiermichael virusvariantspecificclinicalperformanceofasarscov2rapidantigentestwithfocusonomicronvariantsofconcern |